Karyopharm to participate at the 2025 rbc capital markets global healthcare conference

Newton, mass. , may 19, 2025 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the company's senior management team will participate at the 2025 rbc capital markets global healthcare conference in a fireside chat on wednesday, may 21 at 10:00 a.m.

KPTI Ratings Summary

KPTI Quant Ranking